This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Using multiple cards for rewards can significantly boost your benefits. Find out how to optimize your spending for maximum returns.
17,302 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
This guide dives into groupon (grpn) 2026 earnings, breaking down the first-quarter insights, revenue streams, and ke...
Rigetti Computing stock just took a sharp turn lower, surprising many investors who had hoped for a steady rise in a ...
Got $1,000 to invest? This article outlines a real-world plan, explains why Nvidia makes sense before Micron, and giv...
Magnite's 2025 earnings outlook centers on growing connected TV demand, platform efficiency, and navigating ad-tech p...
As software stocks wobble in 2026, one AI-first winner could rise from the noise. This article breaks down why a sele...
November looms as a potential turning point for Take-Two. This article breaks down how the company could turn a block...
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Rumors swirl about a $60.50 per share bid for PayPal by Stripe and Advent, with Block joining the mix. The real prize...
Dream of four rental properties by 40? This real-world guide shows a clear path—from loans to cash flow—to turn that ...
A rising fintech stock year story shows profits climbing while a major fund trims nearly $300M from its stake. The mo...
A high-profile insider sale at Amplitude raises questions for investors. This guide breaks down what amplitude's co-f...